Group A Streptococcus: Full Value of Vaccine Assessment (FVVA) Report
Bloom, D; Cadarette, D; Ferranna, M; Tortorice, D; Excler, J; Mogasale, V; Seok Lee, J; Kim, S; Abbas, K
; Wiley, R; +8 more...Mullin, A; Walkinshaw, D; Williams, M; Scarapicchia, T; Wright, M; Cannon, J; Miller, K; Giannini, F and
(2023)
Group A Streptococcus: Full Value of Vaccine Assessment (FVVA) Report.
Project Report.
Strep A Vaccine Global Consortium (SAVAC).
https://savac.ivi.int/documents/FVVA%20Report_Stre...
; Wiley, R; +8 more...Mullin, A; Walkinshaw, D; Williams, M; Scarapicchia, T; Wright, M; Cannon, J; Miller, K; Giannini, F and
(2023)
Group A Streptococcus: Full Value of Vaccine Assessment (FVVA) Report.
Project Report.
Strep A Vaccine Global Consortium (SAVAC).
https://savac.ivi.int/documents/FVVA%20Report_Stre...
Studies conducted as part of this Full Value of Vaccines Assessment (FVVA) work have revealed important new findings related to the health, economic, and social burden of Strep A globally, as well as the potential public health impact and return on investment in research and development (R&D) spending on a Strep A vaccine.
-
picture_as_pdf - FVVA Report_Strep A Vaccine_27Feb2025_updated.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads